Literature DB >> 17393942

Socioeconomic status and length of hospital stay in children with vaso-occlusive crises of sickle cell disease.

Angela M Ellison1, Howard Bauchner.   

Abstract

OBJECTIVE: To examine the association between socioeconomic status and length of hospital stay for vaso-occlusive crises in children with sickle cell disease.
METHODS: 19,174 discharges (aged 1-20 years), with a primary diagnosis of sickle cell disease with crisis were analyzed from the Healthcare Cost and Utilization Project Kid Inpatient Database 2000. Socioeconomic status was assessed using an area-based measure, median household income by ZIP code and an individual-level measure, insurance status. We adjusted for age, gender, hospital location/teaching status, presence of pneumonia, number of diagnoses on record and number of procedures performed. Negative binomial regression models using generalized estimating equations (GEE) were used to assess length of stay.
RESULTS: Socioeconomic status as measured by income was not associated with length of stay (incidence rate ratio (highest versus lowest category) = 1.04 (95% CI: 0.98, 1.11)). In contrast, socioeconomic status as measured by insurance was associated with length of stay [adjusted incidence rate ratio = 1.04 (95% CI: 1.01, 1.08)), although the magnitude of this difference is small and not likely to be clinically important.
CONCLUSIONS: We found no evidence to suggest that socioeconomic status has any clinically important effect on length of hospital stay in children with vaso-occlusive crises in sickle cell disease.

Entities:  

Mesh:

Year:  2007        PMID: 17393942      PMCID: PMC2569638     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  16 in total

1.  Risk factors for asthma morbidity and mortality in a large metropolitan city.

Authors:  M Castro; K B Schechtman; J Halstead; G Bloomberg
Journal:  J Asthma       Date:  2001-12       Impact factor: 2.515

2.  Do the poor cost more? A multihospital study of patients' socioeconomic status and use of hospital resources.

Authors:  A M Epstein; R S Stern; J S Weissman
Journal:  N Engl J Med       Date:  1990-04-19       Impact factor: 91.245

3.  Prediction of adverse outcomes in children with sickle cell disease.

Authors:  S T Miller; L A Sleeper; C H Pegelow; L E Enos; W C Wang; S J Weiner; D L Wethers; J Smith; T R Kinney
Journal:  N Engl J Med       Date:  2000-01-13       Impact factor: 91.245

4.  Natural history of sickle cell disease--the first ten years.

Authors:  D R Powars
Journal:  Semin Hematol       Date:  1975-07       Impact factor: 3.851

5.  Studies on Rh prophylaxis. 1. Relationship between doses of anti-Rh and size of antigenic stimulus.

Authors:  W Pollack; W Q Ascari; R J Kochesky; R R O'Connor; T Y Ho; D Tripodi
Journal:  Transfusion       Date:  1971 Nov-Dec       Impact factor: 3.157

6.  Pain in sickle cell disease. Rates and risk factors.

Authors:  O S Platt; B D Thorington; D J Brambilla; P F Milner; W F Rosse; E Vichinsky; T R Kinney
Journal:  N Engl J Med       Date:  1991-07-04       Impact factor: 91.245

7.  Frequent and prolonged hospitalizations: a risk factor for early mortality in sickle cell disease patients.

Authors:  Patricia Houston-Yu; Sohail R Rana; Betsy Beyer; Oswaldo Castro
Journal:  Am J Hematol       Date:  2003-03       Impact factor: 10.047

8.  Variations in asthma hospitalizations and deaths in New York City.

Authors:  W Carr; L Zeitel; K Weiss
Journal:  Am J Public Health       Date:  1992-01       Impact factor: 9.308

9.  The association of patients' socioeconomic characteristics with the length of hospital stay and hospital charges within diagnosis-related groups.

Authors:  A M Epstein; R S Stern; J Tognetti; C B Begg; R M Hartley; E Cumella; J Z Ayanian
Journal:  N Engl J Med       Date:  1988-06-16       Impact factor: 91.245

10.  Childhood asthma and poverty: differential impacts and utilization of health services.

Authors:  N Halfon; P W Newacheck
Journal:  Pediatrics       Date:  1993-01       Impact factor: 7.124

View more
  15 in total

1.  Sickle-cell disease in California: a population-based description of emergency department utilization.

Authors:  Julie A Wolfson; Sheree M Schrager; Thomas D Coates; Michele D Kipke
Journal:  Pediatr Blood Cancer       Date:  2010-11-24       Impact factor: 3.167

2.  Association between Hospital Volume and Within-Hospital Intensive Care Unit Transfer for Sickle Cell Disease in Children's Hospitals.

Authors:  Jean L Raphael; Troy Richardson; Matt Hall; Suzette O Oyeku; David G Bundy; Ram V Kalpatthi; Samir S Shah; Angela M Ellison
Journal:  J Pediatr       Date:  2015-10-23       Impact factor: 4.406

3.  Effects of Neighborhood Characteristics on Length of Inpatient Stay: Findings from the U.S. National Data.

Authors:  Huairen Ye; Sungkyu Lee; Hyun Kim
Journal:  Soc Work Res       Date:  2016-03-28

4.  Hospital volume, hospital teaching status, patient socioeconomic status, and outcomes in patients hospitalized with sickle cell disease.

Authors:  Timothy L McCavit; Hua Lin; Song Zhang; Chul Ahn; Charles T Quinn; Glenn Flores
Journal:  Am J Hematol       Date:  2011-04       Impact factor: 10.047

5.  Sickle cell disease in California: sociodemographic predictors of emergency department utilization.

Authors:  Julie A Wolfson; Sheree M Schrager; Rachna Khanna; Thomas D Coates; Michele D Kipke
Journal:  Pediatr Blood Cancer       Date:  2011-02-25       Impact factor: 3.167

6.  Hydroxyurea and acute painful crises in sickle cell anemia: effects on hospital length of stay and opioid utilization during hospitalization, outpatient acute care contacts, and at home.

Authors:  Samir K Ballas; Robert L Bauserman; William F McCarthy; Oswaldo L Castro; Wally R Smith; Myron A Waclawiw
Journal:  J Pain Symptom Manage       Date:  2010-12       Impact factor: 3.612

7.  Renal Failure in Sickle Cell Disease: Prevalence, Predictors of Disease, Mortality and Effect on Length of Hospital Stay.

Authors:  Sri L H Yeruva; Yonette Paul; Patricia Oneal; Mehdi Nouraie
Journal:  Hemoglobin       Date:  2016-09-18       Impact factor: 0.849

8.  Inpatient management of sickle cell pain: a 'snapshot' of current practice.

Authors:  Scott T Miller; Hae-Young Kim; Debra Weiner; Carrie G Wager; Dianne Gallagher; Lori Styles; Carlton D Dampier
Journal:  Am J Hematol       Date:  2012-01-09       Impact factor: 10.047

9.  Hydroxycarbamide adherence and cumulative dose associated with hospital readmission in sickle cell disease: a 6-year population-based cohort study.

Authors:  Jifang Zhou; Jin Han; Edith A Nutescu; Victor R Gordeuk; Santosh L Saraf; Gregory S Calip
Journal:  Br J Haematol       Date:  2018-05-16       Impact factor: 6.998

10.  Identifying sickle cell disease cases using administrative claims.

Authors:  Sarah Reeves; Erika Garcia; Mary Kleyn; Michelle Housey; Robin Stottlemyer; Sarah Lyon-Callo; Kevin John Dombkowski
Journal:  Acad Pediatr       Date:  2014-05-29       Impact factor: 3.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.